已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Outcome of Hodgkin Lymphoma Patients With a Posttreatment18F-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography (FDG-PET)–Negative Residual Mass: Systematic Review and Meta-analysis

医学 荟萃分析 正电子发射断层摄影术 淋巴瘤 内科学 置信区间 核医学 肿瘤科
作者
Hugo J.A. Adams,Rutger A. J. Nievelstein,Thomas Christian Kwee
出处
期刊:Pediatric Hematology and Oncology [Taylor & Francis]
卷期号:32 (8): 515-524 被引量:13
标识
DOI:10.3109/08880018.2015.1085934
摘要

To systematically review and meta-analyze the outcome of Hodgkin lymphoma patients with a posttreatment (18)F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET)-negative residual mass. A systematic PubMed/MEDLINE database search was performed. The methodological quality of included studies was assessed. The number of patients with a posttreatment non-FDG-avid residual mass and the number of these patients who developed disease relapse during follow-up were extracted from each included study. Heterogeneity in disease relapse proportions across individual studies was assessed using the I2 test, with heterogeneity defined as I(2) > 50%. Using a Freeman-Tukey transformation, the disease relapse proportions from each individual study were then meta-analyzed with either a fixed-effects model (if I2 ≤ 50 %) or a random-effects model (if I2 > 50 %). A total of 5 studies comprising a total of 727 Hodgkin lymphoma patients with an FDG-PET-negative residual mass after first-line therapy were included. The overall quality of included studies was moderate. The proportion of patients with a posttreatment non-FDG-avid residual mass who experienced disease relapse during follow-up ranged between 0% and 13.8%. There was heterogeneity in disease relapse proportions across individual studies (I2 = 61.4%). Pooled disease relapse proportion (random effects) was 6.8% (95% confidence interval: 2.6%-12.5%). The disease relapse rate in Hodgkin lymphoma patients with a FDG-PET-negative residual mass after first-line therapy is approximately 6.8%. Considering the existing literature, the presence of a non-FDG-avid residual mass has not been proven yet to be associated with a worse outcome than a posttreatment FDG-PET-based complete remission status without a residual mass.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
爱you发布了新的文献求助10
刚刚
郭峰发布了新的文献求助10
刚刚
风吹麦浪的应助被萧笙采纳,获得10
刚刚
刚刚
1秒前
3秒前
月亮喜欢吃月饼完成签到 ,获得积分10
4秒前
科目三的应助被高兴的高山采纳,获得10
4秒前
4秒前
5秒前
朝阳夕赏发布了新的文献求助10
6秒前
李煜东发布了新的文献求助10
6秒前
8秒前
顾矜的应助被科研通管家采纳,获得10
8秒前
liwenyu2002的应助被科研通管家采纳,获得10
8秒前
领导范儿的应助被科研通管家采纳,获得10
8秒前
Akim的应助被科研通管家采纳,获得10
9秒前
生动飞凤完成签到 ,获得积分10
9秒前
今后的应助被科研通管家采纳,获得10
9秒前
null的应助被科研通管家采纳,获得10
9秒前
共享精神的应助被科研通管家采纳,获得10
9秒前
9秒前
华仔的应助被科研通管家采纳,获得10
9秒前
null的应助被科研通管家采纳,获得10
9秒前
华仔的应助被科研通管家采纳,获得10
9秒前
香蕉觅云的应助被科研通管家采纳,获得10
10秒前
10秒前
刘膝关节健康完成签到 ,获得积分10
11秒前
月亮喜欢吃月饼关注了科研通微信公众号
11秒前
树123发布了新的文献求助10
11秒前
11秒前
秋风的应助被浮云采纳,获得20
11秒前
包容耳机发布了新的文献求助10
12秒前
大个的应助被fyz采纳,获得10
12秒前
Akim的应助被Clarissa采纳,获得10
12秒前
12秒前
轻松乐巧完成签到 ,获得积分10
12秒前
秋风的应助被隐形的凡阳采纳,获得10
13秒前
JamesPei的应助被十安采纳,获得10
13秒前
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179129
求助须知:如何正确求助?哪些是违规求助? 9569710
关于积分的说明 21806324
捐赠科研通 7774507
什么是DOI,文献DOI怎么找? 3433008
关于科研通互助平台的介绍 2556912
邀请新用户注册赠送积分活动 2478649